ImmunityBio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
/ 
Frequently asked questions
To buy ImmunityBio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ImmunityBio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ImmunityBio Inc. is IBRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ImmunityBio Inc. has its primary listing on NASDAQ. You can trade ImmunityBio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ImmunityBio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ImmunityBio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ImmunityBio Inc..